Home/Immunovent/Kate Rochlin, PhD
KR

Kate Rochlin, PhD

Chief Scientific Officer

Immunovent

Therapeutic Areas

Immunovent Pipeline

DrugIndicationPhase
LAMB-Dx Allergy DiagnosticFood and Respiratory AllergiesPre-clinical